Company founded by 4BIO Capital and Professor Steve Pollard as a spinout from the University of Edinburgh to commercialise its breakthrough Synthetic Super-Enhancer platform, Odysseus, to enable ...

In 2016, cancer biologist Johanna Joyce of the Memorial Sloan Kettering Cancer Center published a study in Science that ...

Eight UK hospitals will take place in the international trial to find the world's cancer 'super survivors' - people who ...

Being able to discern a cancer cell in situ from a healthy cell without relying on a surface antigen is truly revolutionary." ...

Sadly, it’s too late for Adam, but I hope the money we’ve donated is life-changing and brings the day closer when a cure is ...

A cancer-killing virus has shown promise in tackling an aggressive type of brain tumour, researchers say. Certain viruses ...

Filippo Veglia, Ph.D., of Wistar’s Genome Regulation and Cell Signaling Program, discusses the most lethal form of brain cancer.

TV star Davina McCall has revealed she's facing surgery for a benign brain tumour, joining a list of celebrities who've battled a similar diagnosis ...

Biomednewsbreaks CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advances Glioblastoma Treatment With Berubicin Amid Strong Financial Position ...

I'm A Celebrity... Get Me Out Of Here! star Annabel Giles died just five months after being diagnosed with a brain tumour ...

A family who are facing Christmas without their beloved little boy are remembering him by naming an adorable miniature pig in ...

CNS Pharmaceuticals plans to engage the FDA and obtain feedback on the design of a study focused on the registration of TPI 287 in recurrent GBM. The net loss for the three months ended September 30, ...